Okra mucilage as an encapsulating agent for magnesium hydroxide nano-capsules in oral drug delivery

Abstract The study investigates the utilization of okra mucilage as an encapsulating agent for the development of magnesium hydroxide nano-capsules for oral drug delivery systems. Given the advancements in drug delivery systems (DDSs) and the emerging interest in nanostructured drug delivery systems...

Full description

Saved in:
Bibliographic Details
Main Authors: Masoud Safari Yazd, Amirreza Shafieeha, Fatemeh Eslami, Leila Zargarzadeh
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-06274-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849238700438847488
author Masoud Safari Yazd
Amirreza Shafieeha
Fatemeh Eslami
Leila Zargarzadeh
author_facet Masoud Safari Yazd
Amirreza Shafieeha
Fatemeh Eslami
Leila Zargarzadeh
author_sort Masoud Safari Yazd
collection DOAJ
description Abstract The study investigates the utilization of okra mucilage as an encapsulating agent for the development of magnesium hydroxide nano-capsules for oral drug delivery systems. Given the advancements in drug delivery systems (DDSs) and the emerging interest in nanostructured drug delivery systems (NDDSs), the potential of okra mucilage for nanoencapsulation is explored. NDDSs hold promise for enhancing therapeutic efficacy while minimizing adverse effects. Okra mucilage is known for its biodegradability, non-toxicity, and cost-effectiveness, making it a suitable candidate for encapsulation processes. The sol–gel encapsulation method is employed to fabricate the encapsulated magnesium hydroxide particles (EMgPs). The EMgPs were characterized using XRD, FT-IR, Raman spectroscopy, and FESEM/EDS, confirming the successful encapsulation of magnesium hydroxide within the okra mucilage. The hydrophilic properties of the EMgPs were also assessed through contact angle measurements, revealing promising wettability for efficient drug release in the digestive system. Release tests in a simulated digestive system environment demonstrated a controlled and sustained release profile (zero-order release) of magnesium hydroxide from the EMgPs with a rate constant of 0.75 and 0.2894 mg mL−1 h−1 in gastric phase and intestinal phase, respectively. The findings highlight the potential of okra mucilage as an encapsulating agent in oral drug delivery systems and provide insights for further research in the field of nanomedicine.
format Article
id doaj-art-817d25eb0e10426f9a86e63e26efb84f
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-817d25eb0e10426f9a86e63e26efb84f2025-08-20T04:01:25ZengNature PortfolioScientific Reports2045-23222025-07-0115111210.1038/s41598-025-06274-5Okra mucilage as an encapsulating agent for magnesium hydroxide nano-capsules in oral drug deliveryMasoud Safari Yazd0Amirreza Shafieeha1Fatemeh Eslami2Leila Zargarzadeh3Department of Chemical Engineering, Tarbiat Modares UniversityDepartment of Chemical Engineering, Amirkabir University of Technology (Tehran Polytechnic)Department of Chemical Engineering, Tarbiat Modares UniversityDepartment of Chemical Engineering, Amirkabir University of Technology (Tehran Polytechnic)Abstract The study investigates the utilization of okra mucilage as an encapsulating agent for the development of magnesium hydroxide nano-capsules for oral drug delivery systems. Given the advancements in drug delivery systems (DDSs) and the emerging interest in nanostructured drug delivery systems (NDDSs), the potential of okra mucilage for nanoencapsulation is explored. NDDSs hold promise for enhancing therapeutic efficacy while minimizing adverse effects. Okra mucilage is known for its biodegradability, non-toxicity, and cost-effectiveness, making it a suitable candidate for encapsulation processes. The sol–gel encapsulation method is employed to fabricate the encapsulated magnesium hydroxide particles (EMgPs). The EMgPs were characterized using XRD, FT-IR, Raman spectroscopy, and FESEM/EDS, confirming the successful encapsulation of magnesium hydroxide within the okra mucilage. The hydrophilic properties of the EMgPs were also assessed through contact angle measurements, revealing promising wettability for efficient drug release in the digestive system. Release tests in a simulated digestive system environment demonstrated a controlled and sustained release profile (zero-order release) of magnesium hydroxide from the EMgPs with a rate constant of 0.75 and 0.2894 mg mL−1 h−1 in gastric phase and intestinal phase, respectively. The findings highlight the potential of okra mucilage as an encapsulating agent in oral drug delivery systems and provide insights for further research in the field of nanomedicine.https://doi.org/10.1038/s41598-025-06274-5NanoencapsulationOkra mucilageMagnesium hydroxide nano-capsulesOral drug delivery systemsPlant-based encapsulating agentsControlled release
spellingShingle Masoud Safari Yazd
Amirreza Shafieeha
Fatemeh Eslami
Leila Zargarzadeh
Okra mucilage as an encapsulating agent for magnesium hydroxide nano-capsules in oral drug delivery
Scientific Reports
Nanoencapsulation
Okra mucilage
Magnesium hydroxide nano-capsules
Oral drug delivery systems
Plant-based encapsulating agents
Controlled release
title Okra mucilage as an encapsulating agent for magnesium hydroxide nano-capsules in oral drug delivery
title_full Okra mucilage as an encapsulating agent for magnesium hydroxide nano-capsules in oral drug delivery
title_fullStr Okra mucilage as an encapsulating agent for magnesium hydroxide nano-capsules in oral drug delivery
title_full_unstemmed Okra mucilage as an encapsulating agent for magnesium hydroxide nano-capsules in oral drug delivery
title_short Okra mucilage as an encapsulating agent for magnesium hydroxide nano-capsules in oral drug delivery
title_sort okra mucilage as an encapsulating agent for magnesium hydroxide nano capsules in oral drug delivery
topic Nanoencapsulation
Okra mucilage
Magnesium hydroxide nano-capsules
Oral drug delivery systems
Plant-based encapsulating agents
Controlled release
url https://doi.org/10.1038/s41598-025-06274-5
work_keys_str_mv AT masoudsafariyazd okramucilageasanencapsulatingagentformagnesiumhydroxidenanocapsulesinoraldrugdelivery
AT amirrezashafieeha okramucilageasanencapsulatingagentformagnesiumhydroxidenanocapsulesinoraldrugdelivery
AT fatemeheslami okramucilageasanencapsulatingagentformagnesiumhydroxidenanocapsulesinoraldrugdelivery
AT leilazargarzadeh okramucilageasanencapsulatingagentformagnesiumhydroxidenanocapsulesinoraldrugdelivery